Age: 53.0
Sex: U
Vaccine: COVID19
Symptoms: Limb discomfort, Loss of personal independence in daily activities, Myalgia, Nasopharyngitis, Pain
Clinical narrative: Cold; flu symptoms; Runny nose; cough; low energy; Could not perform some work.; limited movements; Sharp muscle pain; I can not lift my arm, or stretch and I am not able to undo my bra; discomfort; pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient. Other Case identifier(s): US-PFIZER INC-202200269402 (Pfizer).  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 06Nov2021 (Lot number: 30155BA/SR451) at the age of 53 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "cold", start date: 24Dec2021 (unspecified if ongoing); "flu symptoms", start date: 24Dec2021 (unspecified if ongoing). Concomitant medication(s) included: ADVIL [IBUPROFEN]; TYLENOL. Vaccination history included: Bnt162b2 (Dose:1, Pfizer/BioNTech covid-19 vaccine details, Dose: 1st , Date/time, Date: 20Apr2021, Site and route of injection, Anatomical site of injection: left side shoulder, Route of administration: Intramuscular (checked), Batch/Lot number: ER8735), administration date: 20Apr2021, when the patient was 53 years old, for COVID-19 immunization; Bnt162b2 (Dose:2, Pfizer/BioNTech covid-19 vaccine details, Dose: 2nd , Date/time, Date: 11May2021, Time: around 3-4PM, Site and route of injection, Anatomical site of injection: left side shoulder, Route of administration: Intramuscular (checked), Batch/Lot number: EW0182), administration date: 11May2021, when the patient was 53 years old, for COVID-19 immunization. The following information was reported: LIMB DISCOMFORT (disability, medically significant) with onset 12Nov2021, outcome "not recovered", described as "I can not lift my arm, or stretch and I am not able to undo my bra"; DISCOMFORT (non-serious) with onset Nov2021, outcome "unknown", described as "discomfort"; PAIN (non-serious) with onset Nov2021, outcome "unknown", described as "pain"; NASOPHARYNGITIS (non-serious) with onset 24Dec2021, outcome "unknown", described as "Cold"; INFLUENZA (non-serious) with onset 24Dec2021, outcome "unknown", described as "flu symptoms"; RHINORRHOEA (non-serious) with onset 24Dec2021, outcome "unknown", described as "Runny nose"; COUGH (non-serious) with onset 24Dec2021, outcome "unknown", described as "cough"; ASTHENIA (non-serious) with onset 24Dec2021, outcome "unknown", described as "low energy"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 12Nov2021, outcome "unknown", described as "Could not perform some work."; HYPOKINESIA (non-serious) with onset 12Nov2021, outcome "unknown", described as "limited movements"; MYALGIA (non-serious) with onset 12Nov2021, outcome "unknown", described as "Sharp muscle pain". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (05Jan2022) negative, notes: Test type: Sars-COV 2 RNA, QL RT PCR (Covid-19). Therapeutic measures were taken as a result of limb discomfort.  Clinical information: Due to not having health benefits mostly at home remedies could not afford going to doctors on physical therapy. Constantly have to be aware of my next move with my left arm if I want to avoid pain. Pain is so sharp. I have to freeze for a minute with my eyes closed until it goes away. I will really appreciate if you could provide me with some kind of remedies to get rid of the pain. It also could be examining with following up pain relieve help from your side.   Follow-up (14Feb2022): This is a spontaneous follow-up report received from same contactable consumer. This consumer (patient) reported in response to Non-HCP letter sent which included that: Updated information included: reporter name, phone number, Zip code,  historical vaccine details. Lab test, dosage regimens, vaccine information, vaccine facility information, event treatment, seriousness criteria, New events with onset date, concomitant drugs.  Follow-Up (17Feb2022): Follow-up attempts are completed. No further information is expected